# Boston Scientific to acquire BTG plc for £3.3B

Boston Scientific announced a recommended offer to acquire BTG plc, a UK-based company specializing in minimally-invasive treatments for cancer and vascular diseases, for approximately £3.3 billion ($4.2 billion). The transaction is expected to close in the first half of 2019.

- Type: Acquisition
- Announced: 2018-11-20
- Where: United Kingdom
- Value: $4.20B (3.30B GBP)
- Status: announced
- Products: minimally-invasive cancer treatments, vascular intervention products, acute care pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [BTG Plc](https://endata.com/companies/34199.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2018-11-20-Boston-Scientific-Announces-Recommended-Offer-to-Acquire-BTG-plc), 2018-11-20: "Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc."
- [sec.gov](https://www.sec.gov/Archives/edgar/data/885725/000110465918069709/a18-40570_18k.htm), 2018-11-23: "On November 20, 2018, Bravo Bidco Limited... and BTG plc... issued an announcement... disclosing the terms of a recommended cash offer by Bidco for the entire issued and to be issued share capital of BTG."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.